NICE Upholds Advice Against NHS Use Of Orexigen’s Obesity Drug Mysimba

 
• By Ian Schofield
  
Rejected
NICE has confirmed its decision not to recommend Mysimba for NHS use

More from Market Access

More from Pink Sheet